Why RWD and RWE are Poised to Continue Gaining Ground in 2022

13-Jan-2022 by Brian Buntz

While the present adoption of real-world data (RWD) and real-world evidence (RWE) remains early, such data promise to accelerate regulatory decision-making and support the approval of new indications for drugs already on the market.

Read More